Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Jupiter Neurosciences (NASDAQ: JUNS) Shares Surge 57% on $100 Million PharmAla MDMA Licensing Deal

Jupiter Neurosciences (NASDAQ: JUNS) shares surged approximately 57% after the company secured a $100 million licensing agreement with PharmAla Biotech for the exclusive U.S. rights to the patented non-racemic MDMA candidate ALA-002.

Nitish Kishor | 21 July 2026

CDT Equity (NASDAQ: CDT) Shares Rise 14% After Finalizing 20% Stake in Sarborg

CDT Equity (NASDAQ: CDT) shares closed up 14% at $3.56 after the company disclosed in a recent filing that it finalized the acquisition of 1,020 shares of Sarborg on February 20, 2026.

Nitish Kishor | 21 July 2026

Collegium Pharmaceutical (NASDAQ: COLL) to Relocate Headquarters to Downtown Boston by Q1 2027

Collegium Pharmaceutical (NASDAQ: COLL) disclosed its intention to shift its corporate base to One Lincoln within downtown Boston by the first quarter of 2027.

Nitish Kishor | 21 July 2026

Akari Therapeutics (NASDAQ: AKTX) Shares Rise 6% Pre-Market on Whitehawk ADC Research Alliance

Akari Therapeutics, Plc (NASDAQ: AKTX) shares rose approximately 6% in pre-market trading after the company announced a preclinical research alliance with Whitehawk Therapeutics.

Nitish Kishor | 21 July 2026

Amwell (NYSE: AMWL) Soars to a New 52-Week High as Strong Earnings Momentum and Telehealth Optimism Fuel Investor Interest

American Well Corporation, widely known asAmwell, captured investor attention after its shares surged to a new 52-week high during the latest trading session. The stock climbed to an intraday high of$13.25before closing at$13.23, gaining20.82%on trading volume of approximately452,400 shares. The shares finished virtually at …

Nitish Kishor | 20 July 2026

Agilon Health (NYSE: AGL) Surges to a New 52-Week High as Value-Based Care Momentum Strengthens Ahead of Key Earnings

• agilon Health shares climbed to a fresh 52-week high as investors continued rewarding companies exposed to the expanding value-based care market and improving Medicare Advantage fundamentals.

Nitish Kishor | 20 July 2026

Personalis (NASDAQ: PSNL) Shares Surge 72.5% Year-to-Date as Tempus AI, Inc. Acquisition Looms

Personalis, Inc. The disclosure arrives as the company continues discussions on a potential merger with Tempus AI, Inc. an arrangement that could reshape its strategic direction within the highly competitive biotech environment.

Vinay Lochav | 20 July 2026

UnitedHealth Group Target Raised to $470 as Analyst Highlights Optum Momentum

UnitedHealth Group’s valuation received a decisive lift as senior analyst David H. Toung raised the price target to $470. The adjustment reflects growing confidence that the company’s Optum unit can sustain earnings despite higher medical‑care costs. Investors with exposure to managed‑care and health‑services equities …

Vinay Lochav | 20 July 2026

New Armata (NYSE American: ARMP) CFO Receives $300,000 Annual Equity Grant Amid Market Challenges

The appointment, effective 17 July 2026, comes after House served as Senior Vice President of Finance and principal financial officer, where he played a key role in financial planning and reporting. His compensation structure includes a target annual bonus opportunity equal to fifty percent …

Vinay Lochav | 20 July 2026

Healthrise Deploys $30M Outside Sales Team, Boosts Commercial Growth

The unit, anchored by regional vice presidents Albert Bezjian and Richard Caruso and national account executive Gett Johnson, is tasked with capturing a $30 million client portfolio and extending the firm’s reach into hospital financial management. By adding seasoned executives with decades of treasury …

Vinay Lochav | 20 July 2026
Support

Hi! How can we help you today?

Loading…